Advertisement

Topics

GI Dynamics Announces Scientific Advisory Board Members to Further Scientific Understanding of EndoBarrier

16:57 EDT 12 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
GI Dynamics®, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and obesity, announced additional members of the...

Other Sources for this Article

Investor Relations
United States:
For GI Dynamics, Inc.:
Monica Bellevue, 781-357-3246
Investor Relations

NEXT ARTICLE

More From BioPortfolio on "GI Dynamics Announces Scientific Advisory Board Members to Further Scientific Understanding of EndoBarrier"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...